$BTM
Bitcoin Depot Inc.

2022 Q4 Form 10-K Financial Statement

#000119312523085737 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $0.00 $0.00 $152.0M
YoY Change -100.0%
Cost Of Revenue $123.8M $567.7M $129.8M
YoY Change -4.62% 18.2%
Gross Profit $25.90M $79.10M $22.20M
YoY Change 16.67% 15.14%
Gross Profit Margin 14.61%
Selling, General & Admin $896.7K $5.279M $10.90M
YoY Change -91.77% 52690.5%
% of Gross Profit 3.46% 6.67% 49.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.410M $18.78M $4.610M
YoY Change -4.34% 44.35%
% of Gross Profit 17.03% 23.74% 20.77%
Operating Expenses $896.7K $5.279M $15.60M
YoY Change -94.25% 52690.5%
Operating Profit $25.00M -$5.279M -$10.97K
YoY Change -228128.36% -107.69%
Interest Expense $2.638M $4.442M -$2.900M
YoY Change -190.96% -155.53%
% of Operating Profit 10.55%
Other Income/Expense, Net $0.00 $4.442M $0.00
YoY Change -4542.48%
Pretax Income $1.741M -$836.6K -$10.97K
YoY Change -15979.53% 8265.66%
Income Tax $543.4K $890.8K $0.00
% Of Pretax Income 31.21%
Net Earnings $1.198M -$1.727M -$10.97K
YoY Change -11023.76% 17173.35%
Net Earnings / Revenue -0.01%
Basic Earnings Per Share
Diluted Earnings Per Share $0.03 -$0.04 -$0.31
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $477.2K $477.2K
YoY Change 1093.0%
Cash & Equivalents $477.0K $37.50M $44.74K
Short-Term Investments
Other Short-Term Assets $500.4K $500.4K
YoY Change -94.44%
Inventory
Prepaid Expenses $500.4K
Receivables $263.0K $300.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $977.6K $977.6K $44.74K
YoY Change 2085.14% 2344.03%
LONG-TERM ASSETS
Property, Plant & Equipment $38.96M $39.00M
YoY Change -14.47%
Goodwill $8.717M
YoY Change
Intangibles $540.0K
YoY Change
Long-Term Investments $325.4M $325.4M
YoY Change
Other Assets $14.39M $0.00
YoY Change -100.0%
Total Long-Term Assets $325.4M $325.4M $350.2K
YoY Change 92828.41% 92881.78%
TOTAL ASSETS
Total Short-Term Assets $977.6K $977.6K $44.74K
Total Long-Term Assets $325.4M $325.4M $350.2K
Total Assets $326.4M $326.4M $394.9K
YoY Change 82548.97% 83595.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $105.6K $105.6K
YoY Change -98.94%
Accrued Expenses $3.184M $3.385M $300.0K
YoY Change 961.49% 1028.18%
Deferred Revenue $19.00K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $26.49M $26.50M
YoY Change 29.9%
Total Short-Term Liabilities $4.381M $4.381M $380.9K
YoY Change 1050.14% 1052.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $250.0K $200.0K
YoY Change -85.71%
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.381M $4.381M $380.9K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $4.381M $4.381M
YoY Change 1052.88%
SHAREHOLDERS EQUITY
Retained Earnings -$2.214M -$10.97K
YoY Change 20087.32%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.213M $322.0M $14.04K
YoY Change
Total Liabilities & Shareholders Equity $326.4M $326.4M $394.9K
YoY Change 82548.97% 83595.86%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income $1.198M -$1.727M -$10.97K
YoY Change -11023.76% 17173.35%
Depreciation, Depletion And Amortization $4.410M $18.78M $4.610M
YoY Change -4.34% 44.35%
Cash From Operating Activities -$483.8K -$2.370M -$60.00
YoY Change 806233.33%
INVESTING ACTIVITIES
Capital Expenditures $140.0K $1.110M $2.750M
YoY Change -94.91% -86.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$321.0M $0.00
YoY Change 2718.21%
Cash From Investing Activities $0.00 -$321.0M $0.00
YoY Change 1561.46%
FINANCING ACTIVITIES
Cash Dividend Paid $11.35M
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 323.8M 44.80K
YoY Change -100.0% 809391.0%
NET CHANGE
Cash From Operating Activities -483.8K -2.370M -60.00
Cash From Investing Activities 0.000 -321.0M 0.000
Cash From Financing Activities 0.000 323.8M 44.80K
Net Change In Cash -483.8K 432.5K 44.74K
YoY Change -1181.38% 981.14%
FREE CASH FLOW
Cash From Operating Activities -$483.8K -$2.370M -$60.00
Capital Expenditures $140.0K $1.110M $2.750M
Free Cash Flow -$623.8K -$3.480M -$2.750M
YoY Change -77.32% -56.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
315617500
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001901799
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41305
CY2022 dei Entity Registrant Name
EntityRegistrantName
GSR II Meteora Acquisition Corp.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3203989
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
418 Broadway, Suite N
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Albany
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Auditor Firm
AuditorFirmId
248
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
12207
CY2022 dei City Area Code
CityAreaCode
561
CY2022 dei Local Phone Number
LocalPhoneNumber
532-4682
CY2022 dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
GSRM
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-836566
CY2022 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2022 dei Auditor Location
AuditorLocation
Tulsa, Oklahoma
CY2022Q4 us-gaap Cash
Cash
477195
CY2021Q4 us-gaap Cash
Cash
44739
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
500417
CY2022Q4 us-gaap Assets Current
AssetsCurrent
977612
CY2021Q4 us-gaap Assets Current
AssetsCurrent
44739
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
350201
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
325436230
CY2022Q4 us-gaap Assets
Assets
326413842
CY2021Q4 us-gaap Assets
Assets
394940
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
105642
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3184482
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
300000
CY2022Q4 gsrm Franchise Tax Payable
FranchiseTaxPayable
200050
CY2021Q4 gsrm Franchise Tax Payable
FranchiseTaxPayable
905
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
890770
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
80000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4380944
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
380905
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
324245647
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24209
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2213540
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10965
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2212749
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14035
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
326413842
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
394940
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5079232
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10060
CY2022 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
199813
CY2021Q4 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
905
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-5279045
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-10965
CY2022 gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
-4442480
CY2021Q4 gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
0
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4442480
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10965
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
890770
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1727335
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-10965
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
0
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-10965
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14035
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
12223750
CY2022 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
17710000
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
135698
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
30297501
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1727335
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2212749
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1727335
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-10965
CY2022 gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
-4442480
CY2021Q4 gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
0
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
500417
CY2021Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
105642
CY2021Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3104483
CY2021Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10000
CY2022 gsrm Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
199145
CY2021Q4 gsrm Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
905
CY2022 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
890770
CY2021Q4 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
0
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2370193
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
320993750
CY2021Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-320993750
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
161543
CY2021Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
85000
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
241543
CY2021Q4 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
5000
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
316250000
CY2021Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
12223750
CY2021Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4597351
CY2021Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
60201
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
323796399
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44799
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
432456
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44739
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44739
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477195
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44739
CY2022 gsrm Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
70000
CY2021Q4 gsrm Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
290000
CY2022 gsrm Reversal Of Accrued Offering Costs
ReversalOfAccruedOfferingCosts
290000
CY2021Q4 gsrm Reversal Of Accrued Offering Costs
ReversalOfAccruedOfferingCosts
0
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-10-14
CY2022 gsrm Threshold Minimum Aggregate Fair Market Value As Percentage Of Net Assets Held In Trust Account
ThresholdMinimumAggregateFairMarketValueAsPercentageOfNetAssetsHeldInTrustAccount
0.80
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
5000001
CY2022 gsrm Threshold Percentage Of Public Shares Subject To Redemption Without Company Prior Written Consent
ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent
0.15
CY2022 gsrm Percentage Of Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageOfObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1
CY2022 gsrm Months To Complete Acquisition
MonthsToCompleteAcquisition
P15M
CY2022 gsrm Maximum Period To Complete Acquisitions
MaximumPeriodToCompleteAcquisitions
P17M
CY2022 gsrm Dissolution Expenses
DissolutionExpenses
100000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
477000
CY2022Q4 gsrm Working Capital Deficit
WorkingCapitalDeficit
3400000
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1100000
CY2022 gsrm Estimated Business Combination Date
EstimatedBusinessCombinationDate
2023-06-01
CY2022Q3 gsrm Percentage Of Federal Excise Tax On Stock Buy Back
PercentageOfFederalExciseTaxOnStockBuyBack
0.01
CY2022Q3 gsrm Effective Date For Levy Of Federal Excise Tax On Stock Buy Back
EffectiveDateForLevyOfFederalExciseTaxOnStockBuyBack
2023-01-01
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting periods. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of theses financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December 31, 2022 and 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022 gsrm Restricted Investments Term
RestrictedInvestmentsTerm
P185D
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1976562
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1727335
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-10965
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-29206918
CY2021Q4 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2022 gsrm Net Income Loss Including Accretion Of Temporary Equity To Redemption Value
NetIncomeLossIncludingAccretionOfTemporaryEquityToRedemptionValue
-30934253
CY2021Q4 gsrm Net Income Loss Including Accretion Of Temporary Equity To Redemption Value
NetIncomeLossIncludingAccretionOfTemporaryEquityToRedemptionValue
-10965
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0
CY2022 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
667000
CY2022Q1 gsrm Per Unit Amount Of Marketing Fees May Be Paid At Sole Discretion Of Entity To Third Party Advisors Not Participated In Ipo That Assist In Consummate Business Combination
PerUnitAmountOfMarketingFeesMayBePaidAtSoleDiscretionOfEntityToThirdPartyAdvisorsNotParticipatedInIpoThatAssistInConsummateBusinessCombination
0.00105
CY2022Q1 gsrm Value Of Marketing Fees May Be Paid At Sole Discretion Of Entity To Third Party Advisors Not Participated In Ipo That Assist In Consummate Business Combination
ValueOfMarketingFeesMayBePaidAtSoleDiscretionOfEntityToThirdPartyAdvisorsNotParticipatedInIpoThatAssistInConsummateBusinessCombination
3300000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 gsrm Percentage Of Total Number Of Shares Issued In The Initial Public Offering
PercentageOfTotalNumberOfSharesIssuedInTheInitialPublicOffering
0.20
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1976562
CY2022Q4 us-gaap Shares Issued
SharesIssued
0
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2022Q4 gsrm Deferred Tax Asset Startup Costs
DeferredTaxAssetStartupCosts
300424
CY2021Q4 gsrm Deferred Tax Asset Startup Costs
DeferredTaxAssetStartupCosts
2113
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
190
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
300424
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2303
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
300424
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2303
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
890770
CY2021Q4 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2021Q4 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-298121
CY2021Q4 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2303
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2021Q4 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
298121
CY2021Q4 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2303
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
890770
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2021Q4 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2022 gsrm Effective Income Tax Rate Reconciliation Merger Costs
EffectiveIncomeTaxRateReconciliationMergerCosts
-0.916
CY2021Q4 gsrm Effective Income Tax Rate Reconciliation Merger Costs
EffectiveIncomeTaxRateReconciliationMergerCosts
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.356
CY2021Q4 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.062
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001193125-23-085737-index-headers.html Edgar Link pending
0001193125-23-085737-index.html Edgar Link pending
0001193125-23-085737.txt Edgar Link pending
0001193125-23-085737-xbrl.zip Edgar Link pending
d450576d10k.htm Edgar Link pending
d450576dex311.htm Edgar Link pending
d450576dex312.htm Edgar Link pending
d450576dex321.htm Edgar Link pending
d450576dex322.htm Edgar Link pending
d450576dex47.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gsrm-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
gsrm-20221231_cal.xml Edgar Link unprocessable
gsrm-20221231_def.xml Edgar Link unprocessable
gsrm-20221231_lab.xml Edgar Link unprocessable
gsrm-20221231_pre.xml Edgar Link unprocessable
d450576d10k_htm.xml Edgar Link completed
Show.js Edgar Link pending